Anhui Anke Biotechnology (Group) Co Ltd Sustainability Reports
Anhui Anke Biotechnology (Group) Co., Ltd. focuses on the research, development, manufacturing, and marketing of biopharmaceutical products, particularly genetic engineering drugs. Its portfolio includes recombinant human growth hormones, human interferons, diagnostic reagents, and traditional Chinese medicines.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG001T5C6Q9
2 reports from 2024 to 2025
